Has Manmeet Ahluwalia received payments from drug or device companies?

Yes. Drug and device makers reported $4,760,324 in general payments to Manmeet Ahluwalia across 292 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manmeet Ahluwalia did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manmeet Ahluwalia come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manmeet Ahluwalia

Hematology & Oncology · Miami, FLNPI 1760623557

Payments from drug & device makers

$4,760,324in general payments, 2019–2025

Across 292 payments — averaging $16,302 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1.3M
Merck$1M
Incyte Corporation$571K
Pfizer$422K
Insightec,ltd$361K
Seagen Inc.$289K
plus $799K from 35 others

$2,000in research payments, 2019–2025

Across 2 payments — averaging $1000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Icad, Inc$2K

What the payments were for

Consulting fees$93,13891%
Speaking & faculty fees$3,4773%
Travel & lodging$2,4322%
Food & beverage$3,8334%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	5	$1,271,417
Merck	7	$1,046,659
Incyte Corporation	96	$571,458
Pfizer	23	$421,704
Insightec,ltd	40	$361,190
Seagen Inc.	6	$289,063
Bayer	19	$241,889
Pharmacyclics LLC, An Abbvie Company	1	$159,054
Kadmon Corporation LLC	3	$120,766
E.r. Squibb & Sons, L.L.C.	4	$65,189
Eli Lilly	1	$33,584
Janssen Research & Development, LLC	2	$27,573
Array Biopharma Inc	8	$26,192
Mirati Therapeutics, Inc.	2	$17,500
Insightec,inc	10	$17,092
Servier Pharmaceuticals LLC	4	$16,327
AbbVie	11	$13,859
Siemens Medical Solutions USA, Inc.	4	$11,223
Beigene, Ltd.	4	$8,746
Novocure Inc.	5	$8,334
Viewray Technologies Inc	4	$5,800
Celularity Inc.	6	$5,667
Recordati_rare_diseases_inc.	1	$4,410
Novocure Israel Ltd	1	$3,300
GT Medical Technologies, Inc	3	$2,633
GSK	1	$2,600
Sumitomo Pharma America, Inc.	1	$2,560
Janssen Global Services, LLC	1	$2,480
Boehringer Ingelheim Pharma GmbH & Co.kg	1	$880
Brainlab, Inc.	4	$356
Janssen Scientific Affairs, LLC	2	$219
Blue Earth Diagnostics	2	$123
Rigel Pharmaceuticals, Inc.	1	$103
Astrazeneca UK Limited	1	$88
Elekta, Inc.	1	$70
Caris MPI, Inc.	1	$62
Immunitybio, Inc.	1	$40
Johnson & Johnson	1	$37
Beone Medicines USA, Inc.	2	$35
Illumina, Inc.	1	$25
Pharmacosmos Therapeutics Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,760,324 in reported general payments places this provider in the 95th percentile of 694 hematology & oncology providers in Florida.

See all hematology & oncology providers in Florida →

Other hematology & oncology in Miami

Carl LandgrenMiami$47.8M
Dickran KazandjianMiami$8.4M
Justin WattsMiami$7.9M
Jaime MerchanMiami$7.9M
Frances ValdesMiami$5.7M
Izidore LossosMiami$4.4M
Gerald SoffMiami$4.3M
James HoffmanMiami$3.3M
Ana Sandoval LeonMiami$3.2M
Julio ChavezTampa$16.4M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →